Important Notice Regarding Oxervate

Posted in Latest News on January 24, 2020.

During the January 17, 2020 Board of Optometry meeting, the Board approved Oxervate (Cenergermin-bkbj) 0.002% for addition to Rule 64B13-18.002, Florida Administrative Code – Formulary of Topical Pharmaceutical Agents.

Important Note: At this time, Oxervate cannot be prescribed by Certified Optometrists in Florida until the rule has been approved. Once the rule has gone through the approval process, notice will be provided on the board website and both may be prescribed by Certified Optometrists at that time.



More Latest News

2021-2022 Annual Report and Long-Range Plan Released 
October 31, 2022

The Annual Report and Long-Range Plan for Fiscal Year 2021-22 has been published. Click here for more information. Continue reading


Hometown Heroes
October 12, 2022

The Florida Department of Health, Division of Medical Quality Assurance is proud to highlight the Florida Hometown Heroes Housing Program. Continue reading